Retrospective analysis of 119 Chinese noninflammatory locally advanced breast cancer cases treated with intravenous combination of vinorelbine and epirubicin as a neoadjuvant chemotherapy: a median follow-up of 63.4 months

Table 2 Relations between pre-ER and Pathological Response in Tumor Site

Pathological Response in Tumor Site	pre-ER			p value
	negative	positive	total
pCR	15(68.2%)	7(31.8%)	22(100%)	0.043
non-pCR	43(44.3%)	54(55.7%)	97(100%)
total	58	61	119

Abbreviations: pCR: pathological complete response; pre-ER:ER status examined before neoadjuvant chemotherapy.

ISSN: 1471-2407